ELIEM THERAPEUTICS INC
CLYM·28658R106·US·Common Stock·Healthcare - Biotechnology-Activist
CLYM (ELIEM THERAPEUTICS INC) is held by 72 institutional investors as of Q2 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($147.4M), FMR LLC ($88.5M), UBS Group AG ($44.4M). Net institutional sentiment: Bullish.
72
Holders
(4 Elite)
$564.4M
Total Value
72% (76)
Consensus
55 buying - 21 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 14, 2026 · Insiders Sep 30, 2026 · Activists Aug 14, 2026 · Congress none
InsiderRLRA CAPITAL MANAGEMENT, L.P.Exercise 40K shSep 28, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Exercise 10K shSep 28, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Exercise 10K shSep 28, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 81
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer